Potential therapeutic application of host defense peptides
- PMID: 20094872
- DOI: 10.1007/978-1-60761-594-1_19
Potential therapeutic application of host defense peptides
Abstract
Host defense peptides (HDPs) are relatively small, mostly cationic, amphipathic, and of variable length, sequence, and structure. The majority of these peptides exhibit broad-spectrum antimicrobial activity and often activity against viruses and some cancer cell lines. In addition, HDPs also provide a range of immunomodulatory activities related to innate immunity defense, inflammation, and wound healing. The development of these multi-faceted molecules and their bioactivities into clinically important therapeutics is being pursued using a number of different approaches. Here we review the role of HDPs in nature and application of this role to the development of novel therapeutics.
Similar articles
-
Host defense peptides and their antimicrobial-immunomodulatory duality.Immunobiology. 2011 Mar;216(3):322-33. doi: 10.1016/j.imbio.2010.07.003. Epub 2010 Aug 19. Immunobiology. 2011. PMID: 20828865 Review.
-
Host defense peptides for use as potential therapeutics.Curr Opin Investig Drugs. 2009 Feb;10(2):164-71. Curr Opin Investig Drugs. 2009. PMID: 19197794 Review.
-
Porcine host defense peptides: expanding repertoire and functions.Dev Comp Immunol. 2009 Mar;33(3):334-43. doi: 10.1016/j.dci.2008.05.006. Epub 2008 Jun 9. Dev Comp Immunol. 2009. PMID: 18579204 Review.
-
The immunology of host defence peptides: beyond antimicrobial activity.Nat Rev Immunol. 2016 May;16(5):321-34. doi: 10.1038/nri.2016.29. Epub 2016 Apr 18. Nat Rev Immunol. 2016. PMID: 27087664 Review.
-
Using antimicrobial host defense peptides as anti-infective and immunomodulatory agents.Expert Rev Anti Infect Ther. 2008 Dec;6(6):887-95. doi: 10.1586/14787210.6.6.887. Expert Rev Anti Infect Ther. 2008. PMID: 19053901 Review.
Cited by
-
Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa.Eur Biophys J. 2011 Apr;40(4):555-64. doi: 10.1007/s00249-011-0679-2. Epub 2011 Feb 11. Eur Biophys J. 2011. PMID: 21312033
-
Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals.J AIDS Clin Res. 2013 Mar 5;4(193):1000193. doi: 10.4172/2155-6113.1000193. J AIDS Clin Res. 2013. PMID: 23730535 Free PMC article.
-
Antimicrobial peptides: utility players in innate immunity.Front Immunol. 2012 Oct 25;3:325. doi: 10.3389/fimmu.2012.00325. eCollection 2012. Front Immunol. 2012. PMID: 23112800 Free PMC article. No abstract available.
-
Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides.Eur Biophys J. 2011 Apr;40(4):371-85. doi: 10.1007/s00249-011-0674-7. Epub 2011 Jan 28. Eur Biophys J. 2011. PMID: 21274708
-
Molecular Dynamics Simulations of the Host Defense Peptide Temporin L and Its Q3K Derivative: An Atomic Level View from Aggregation in Water to Bilayer Perturbation.Molecules. 2017 Jul 22;22(7):1235. doi: 10.3390/molecules22071235. Molecules. 2017. PMID: 28737669 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources